Avedro Receives FDA Approval For Photrexa Viscous, Photrexa And The KXL System For Corneal Cross-Linking

Avedro, Inc., an ophthalmic pharmaceutical and medical device company, has received approval from the U.S. Food and Drug Administration (FDA) for Photrexa Viscous, Photrexa and the KXL System.
Source: Medical Design Online News - Category: Medical Equipment Source Type: news